Arginase catalyzes the Mn(II) dependent hydrolysis of L-arginine to produce L-ornithine and urea in the final reaction of the urea cycle. In liver and non-hepatic tissues, this reaction also supplies L-ornithine for the synthesis of L-Proline and the polyamines, spermine and spermidine. Many important features of the metallobiochemistry of Mn(II) as it relates to the catalytic mechanism of arginase are poorly understood. The role of the intrinsic Mn(II) in arginase structure and function is not known. A major goal of these studies will be to define the function of inorganic cofactors in this reaction. Electron paramagnetic resonance experiments will probe the structure of the binuclear Mn(II) center of arginase recently discovered in this laboratory. Additional studies will assess the effect of the intrinsic Zn(II) on protein conformation and stability. Rat liver arginase has been crystallized in a form eminently suitable for X-ray crystallographic studies. Analysis of crystals diffracting to 2.4. Angstroms resolution has established that rat liver arginase is a trimer. The three dimensional structure of arginase will be determined to high resolution. An expression system for the production of rat liver arginase in E. coli has been developed as source of large quantities of enzyme and for site- directed mutagenesis of critical amino acid residues identified bh chemical modifications and X-ray crystallography. The specific roles of histidine residues in the chemistry of catalysis and metal binding will be established in a series of biochemical, biophysical, and molecular biological studies. We have recently shown that arginase has a catalase activity that requires an intact binuclear Mn(II) center. The catalytic mechanism of this novel activity will be determined through kinetic, spectroscopic and mutagenic approaches. These studies will provide a three dimensional structure of the enzyme, from which the molecular basis for divalent cation specificity and function can be determined. Arginase will serve as a paradigm in structure-function analyses of the enigmatic class of Mn-metalloenzymes, including the Mn-catalase.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044841-04
Application #
2016497
Study Section
Biochemistry Study Section (BIO)
Program Officer
Laughlin, Maren R
Project Start
1993-12-01
Project End
1997-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Temple University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Lavulo, Lopeti T; Emig, Frances A; Ash, David E (2002) Functional consequences of the G235R mutation in liver arginase leading to hyperargininemia. Arch Biochem Biophys 399:49-55
Colleluori, D M; Morris Jr, S M; Ash, D E (2001) Expression, purification, and characterization of human type II arginase. Arch Biochem Biophys 389:135-43
Colleluori, D M; Ash, D E (2001) Classical and slow-binding inhibitors of human type II arginase. Biochemistry 40:9356-62
Lavulo, L T; Sossong Jr, T M; Brigham-Burke, M R et al. (2001) Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid. J Biol Chem 276:14242-8
Cox, J D; Cama, E; Colleluori, D M et al. (2001) Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase. Biochemistry 40:2689-701
Kim, N N; Cox, J D; Baggio, R F et al. (2001) Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry 40:2678-88
Ash, D E; Cox, J D; Christianson, D W (2000) Arginase: a binuclear manganese metalloenzyme. Met Ions Biol Syst 37:407-28
Baggio, R; Emig, F A; Christianson, D W et al. (1999) Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J Pharmacol Exp Ther 290:1409-16
Ash, D E; Scolnick, L R; Kanyo, Z F et al. (1998) Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase. Mol Genet Metab 64:243-9
Esch, F; Lin, K I; Hills, A et al. (1998) Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J Neurosci 18:4083-95

Showing the most recent 10 out of 20 publications